Rhythm Pharmaceuticals
RYTM
RYTM
98 hedge funds and large institutions have $483M invested in Rhythm Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.91% more ownership
Funds ownership: 95.47% → 96.39% (+0.91%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
23% less capital invested
Capital invested by funds: $626M → $483M (-$142M)
Holders
98
Holding in Top 10
1
Calls
$154K
Puts
$90K
Top Buyers
| 1 | +$13.7M | |
| 2 | +$4.62M | |
| 3 | +$1.97M | |
| 4 |
Goldman Sachs
New York
|
+$1.91M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$1.82M |
Top Sellers
| 1 | -$19.5M | |
| 2 | -$2.93M | |
| 3 | -$2.07M | |
| 4 |
DM
Deerfield Management
New York
|
-$1.22M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$999K |